Congratulations to New Jersey for becoming the 19th state to allow entities that serve the public to stock epinephrine auto-injectors (EAIs) for emergency use. A 4094, which allows entities such as youth camps, daycare facilities, restaurants and other public venues to keep EAIs on hand and gives access to them by employees who have completed an approved educational program, was signed by Gov. Chris Christie on Jan. 11. You may read the text of the bill here.
New Jersey is already one of 10 states that requires K-12 schools to stock epinephrine; it also has a separate law that allows colleges and universities to stock EAIs on campus. FARE worked with public officials, issued action alerts asking our members to contact their legislators, and partnered with groups including the Food Allergy and Anaphylaxis Coalition of New Jersey to support this legislation.
New Jersey joins Arkansas, Colorado, Florida, Georgia, Indiana, Iowa, Kentucky, Maine, Michigan, Minnesota, Nevada, North Carolina, Oklahoma, Oregon, Rhode Island, Utah, West Virginia and Wisconsin in allowing the availability of EAIs in designated public places.
Congratulations also to Washington, DC! On Jan. 12, the Council of the District of Columbia approved B21-0005, the Access to Emergency Epinephrine in Schools Act of 2015. The law, now known as Act Number A21-0259, directs the Office of the State Superintendent (OSSE) and the Department of Health (DOH) to issue rules requiring District schools, including private and public charter schools, to adopt and implement policies allowing for the possession and administration of epinephrine auto-injectors. It requires that each District school adopt and implement training policies and procedures for the administration of an epinephrine auto-injector by a school employee, or other person affiliated with a District school, by June 1, 2016, and that each District school possess epinephrine injectors, for emergency use during the school day or at a school affiliated event on school property, by Aug. 1. It also exempts persons rendering emergency epinephrine in District schools from liability.
FARE worked with policy makers and advocates in the District to provide support on this bill.